Researchers developed a ‘virtual biotech’ made up of as many as 37,000 agents reporting to an 'chief scientist'.
After examining the results of thousands of clinical trials, a swarm of AI agents suggested that a protein that dampens immune responses could be the target for a promising treatment for lung cancer.… [+3161 chars]